New publications
Malaria vs. cancerous tumors
Last reviewed: 02.07.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Danish biomedical scientists have made a sensational announcement – they have managed to find a cure for cancer, one of the main problems of our century. The discovery was made by accident – during research related to the development of a vaccine against malaria, scientists found that malaria proteins, if processed in a certain way, can destroy cancer cells, and quite effectively. Such special malaria proteins can destroy more than 90% of atypical cells that slowly kill the human body. Oncologists will test the new cancer drug on volunteers over the next few years.
The research was carried out by a group of scientists at the University of Copenhagen, in addition to the staff of the research institution, Mads Daugaard from Canada took part in the work. The specialists tested an anti-malarial vaccine on pregnant women and found out that the placenta contains a carbohydrate that attracts the malaria parasite, and its structure is similar to that found in cancer cells.
In their report, the scientists explained that in the placenta, this carbohydrate is responsible for accelerated growth, but at the same time, this same carbohydrate promotes the growth of cancerous tumors in the body.
During the study, scientists found that the malaria parasite attacks the cancerous tumor and is immediately attracted to the carbohydrate.
Further work showed that if the toxin is combined with a malarial protein, more than 90% of cancer cells of various types of tumors die – these are truly impressive figures.
The experts decided to test the drug, which combines the toxin with the malaria protein, on laboratory animals that were transplanted with three different types of cancerous tumors – malignant lymphoma (non-Hodgkin's), metastatic bone cancer and prostate cancer.
As a result, the tumor size in rodents with lymphoma decreased by more than 75%, 5 out of 6 rodents with bone cancer survived after 2 months, and in 2 out of 6 rodents with prostate cancer, the cancerous tumor completely disappeared 4 weeks after taking the new drug. It is worth noting that all rodents from the control group that did not receive the new drug died after some time.
According to WHO, cancer is the leading cause of death in the world (cancer is the leading cause of death worldwide). And according to researchers, in 70 years, cancer will kill 70% more people than today.
1/3 of all cancer deaths are associated with 5 risk factors – obesity, sedentary lifestyle, smoking, alcohol consumption, nutrition (mainly lack of vegetables and fruits in the diet).
Now specialists have to find out how effective the new treatment will be for humans. Calculating the correct dosage of active substances is also of great importance. As the scientists stated, they intend to clarify all these issues in their next experiments, but it is already possible to say for sure that the new cancer drug is contraindicated during pregnancy, since the toxin, mistaking the placenta for a tumor (due to the similarity of the carbohydrate structure), will destroy it.
[